Hamburg, Senior Panel Continue “Rethinking” FDA Organization
This article was originally published in The Rose Sheet
Commissioner Margaret Hamburg awaits recommendations from a panel of senior agency officials on how to ensure FDA’s centers support Office of Regulatory Affairs’ activities without duplication.
You may also be interested in...
FDA’s Program Alignment Group recommends “commodity-based and vertically integrated programs” to improve efficiency and communication.
FDA Commissioner Hamburg has appointed 10 officials to come up with a plan to realign the agency, with the goal of moving toward a “specialized program-based model.”
Commissioner Margaret Hamburg’s structural reorganization of FDA leaves the current leadership of the agency’s centers intact, but adds a new layer of management and accountability between the medical product center directors and the commissioner’s office.